Polymyxin B-immobilized fiber column hemoperfusion treatment for drug-induced severe respiratory failure: Report of three cases

Internal Medicine

Volumn 49, Issue 1, 2010, Pages 59-64

  Yokoyama, Toshiki ^a   Tsushima, Kenji ^a   Yamamoto, Hiroshi ^a   Ito, Michiko ^a   Agatsuma, Toshihiko ^a   Kozumi, Tomonobu ^a   Kubo, Keishi ^a  

^a SHINSHU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Drug induced lung disease; Interstitial lung disease; Krebs von den Lungen 6 (KL 6); Polymyxin B immobilized fiber column treatment

Indexed keywords

CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HERBACEOUS AGENT; METHOTREXATE; METHYLPREDNISOLONE; NAFAMSTAT MESILATE; POLYMYXIN B; SANMOTSU OGON TO; UNCLASSIFIED DRUG;

ACUTE RESPIRATORY FAILURE; ADULT; AGED; ARTERIAL OXYGEN TENSION; ARTICLE; CASE REPORT; DISEASE SEVERITY; FEMALE; HEMOPERFUSION; HERBAL MEDICINE; HUMAN; INTERSTITIAL LUNG DISEASE; LIVER CELL DAMAGE; MALE; RESPIRATORY FAILURE; TREATMENT OUTCOME;

AGED; FEMALE; HEMOPERFUSION; HUMANS; IMMOBILIZED PROTEINS; LUNG DISEASES, INTERSTITIAL; MALE; METHOTREXATE; MIDDLE AGED; PLANT EXTRACTS; POLYMYXIN B; RESPIRATORY INSUFFICIENCY;

EID: 74549128552     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.49.2213     Document Type: Article

References (14)

1. Kamata Y, Nara H, Kamimura T, et al. Rheumatoid arthritis complicated with acute interstitial pneumonia induced by leflunomide as an adverse reaction. Intern Med 43: 1201-1204, 2004.
2. Inoue A, Saijo Y, Maemondo M, et al. Severe acute interstitial pneumonia and gefitinib. Lancet 361: 137-139, 2003.
3. Imokawa S, Colby TV, Leslie KO, Helmers RA. Methotrexate pneumonitis: review of the literature and histopathological findings in nine patients. Eur Respir J 15: 373-381, 2000.
4. Shiota Y, Wilson JG, Mashiba H. Adult respiratory distress syndrome induced by a Chinese medicine, Kamisyoyo-San. Intern Med 35: 494-496, 1996.
5. Sakamoto O, Ichikado K, Kohrogi H, Suga M. First clinical and CT characteristics of Chinese medicine-induced acute respiratory distress syndrome. Respirology 8: 344-350, 2003.
6. Kataoka K, Taniguchi H, Hasegawa Y, et al. Interstitial lung disease associated with gefitinib. Respir Med 100: 698-704, 2006.
7. Kondoh Y, Taniguchi H, Yokoi T, et al. Cyclophosphamide and low-dose prednisolone in idiopathic pulmonary fibrosis and fibrosing nonspecific interstitial pneumonia. Eur Respir J 25: 528-533, 2005.
8. Homma S, Sakamoto S, Kawabata M, et al. Cyclosporin treatment in steroid-resistant and acutely exacerbated interstitial pneumonia. Intern Med 44: 1144-1150, 2005.
9. Kodama M, Tani T, Hanasawa H; The PMX Clinical Study Group. Treatment of sepsis by plasma endotoxin removal: hemoperfusion using a polymyxin-B immobilized column. J Endotoxin Res 4: 293, 1997.
10. Tsushima K, Kubo K, Yoshikawa S, et al. Effects of PMX-DHP treatment for patients with directly induced acute respiratory distress syndrome. Ther Apher Dial 11: 138-145, 2007.
11. Yamamoto H, Koizumi T, Kaneki T, Fujimoto K, Kubo K, Honda T. Direct hemoperfusion with polymyxin B immobilized fiber improves shock and hypoxemia during endotoxemia in anesthetized sheep. J Endotoxin Res 8: 419-426, 2002.
12. Kushi H, Miki T, Okamoto K, Nakahara J, Saito T, Tanjoh K. Early hemoperfusion with an immobilized polymyxin B fiber column eliminates humoral mediators and improves pulmonary oxygenation. Crit Care 9: 653-661, 2005.
13. Seo Y, Abe S, Kurahara M, et al. Beneficial effect of polymyxin B-immobilized fiber column (PMX) hemoperfusion treatment on acute exacerbation of idiopathic pulmonary fibrosis. Intern Med 45: 1033-1038, 2006.
14. Ware LB, Matthay MA. The acute respiratory distress syndrome. N Engl J Med 342: 1334-1349, 2000.